Background. Surgical site infection (SSI) is a feared complication in hip arthroplasty, especially following femoral neck fracture in the elderly, associated with substantially increased morbidity, mortality, and costs. Gentamicincontaining collagen sponges are widely used for prevention of SSIs, but their effectiveness in joint replacement surgery remains unclear.
during surgery and continued up to 24 hours after surgery is routinely used in Norway [10] . Despite these prophylactic efforts, SSI continues to be one of the major complications in arthroplasty. Coagulase-negative staphylococci (CoNS) and Staphylococcus aureus are the most common pathogens found [11, 12] .
Gentamicin-containing collagen sponges were developed to prevent and treat SSIs by delivering high local gentamicin concentrations in the wound, avoiding the high systemic concentrations associated with nephrotoxicity [13] . The high local concentrations exceed the minimum inhibitory concentrations of many bacteria. The gentamicin concentration in wound fluid has been found to be high during the first 8-12 postoperative hours, with dissolution up to 7 days, which may give a prolonged prophylactic effect [13, 14] . A large randomized controlled trial (RCT) from Sweden showed a reduction in SSIs by 53% following cardiac surgery in patients where gentamicin-containing collagen sponges were used [15] . However, later RCTs have showed conflicting results [16] [17] [18] [19] [20] . There are no trials of prophylactic use of gentamicin-collagen sponges in patients undergoing joint replacement surgery.
The aim of this study was to evaluate the effect of using local application of gentamicin-containing collagen sponges in addition to systemic antibiotic prophylaxis to reduce SSIs following hemiarthroplasty in patients with femoral neck fractures.
METHODS

Study Design and Participants
This multicenter, single-blind, randomized trial was conducted in 4 district general hospitals and 1 university hospital in Norway. Patients who presented with a displaced femoral neck fracture that was planned to be treated with hemiarthroplasty were eligible for inclusion. Exclusion criteria were allergy to gentamicin, ongoing treatment with aminoglycosides, and/or reduced renal function. Known renal disease or serum creatinine levels not in the normal range were used to estimate reduced renal function. The study was approved by the Regional Ethical Committee. The study was registered with ClinicalTrials.gov (NCT01287780). Written informed consent was obtained from all patients who were able to consent or, if not, from their legally authorized representative.
Randomization and Masking
We randomly assigned patients to routine intravenous prophylaxis and local application of 2 gentamicin sponges, or routine intravenous prophylaxis alone. Randomization was stratified by center and performed using a computer random number generator with blocks of 10. Assignment was concealed. Randomization was performed by opening opaque, sealed, numbered envelopes intraoperatively just before wound closure. Allocation group, and any information on the sponges, was not noted in the medical records, and patients, as well as the ones assessing wound status, were masked to study group assignment. The wounds were mainly assessed by nurses working in the outpatient clinics on a daily basis, and occasionally by surgeons. The primary outcome measure was SSI within 30 days after surgery. To maximize the number of events, any SSI (deep and superficial) was included.
Classification of Infection
SSI was diagnosed based on the Centers for Disease Control and Prevention criteria, which is classified as "superficial incisional," "deep incisional," and "organ or space" [21] . We defined both "deep incisional" and "organ or space" as deep SSI.
Surgical Technique
The patients underwent bipolar hemiarthroplasty with either a cemented femoral stem (Exeter, Stryker, Kalamazoo, Michigan) or an uncemented femoral stem (Corail, DePuy/Johnson & Johnson, Leeds, United Kingdom). They were operated by the orthopedic surgeons on call. No changes in the hospitals' routines were made because of the study. Surgery was performed in standard operating rooms. The patients were either placed in a lateral decubitus position or supine and the arthroplasties were performed through an anterior, a lateral, or a posterior approach, depending on the departmental routines. All patients routinely received systemic antibiotic prophylaxis (cephalothin 2 g) at induction, aiming at 30 minutes before incision, and 3 additional doses within 24 hours. In case of known penicillin allergy, clindamycin 600 mg was given in 3 doses. We used a 10 × 10 × 0.5-cm gentamicin-containing collagen sponge consisting of 280 mg bovine collagen and 130 mg gentamicin sulphate (Collatamp G, Swedish Orphan Biovitrum AS). The treatment group received 2 sponges: 1 in the joint and 1 beneath the fascia. The sponges were applied without premoistening immediately before wound closure. The control group did not receive a placebo sponge, as this theoretically could be a medium for growth of bacteria. The wound was closed in layers. Drainage was not used.
Follow-up
Demographic and surgical data were recorded for all patients. Medical conditions were identified through the medical records. Serum creatinine was measured preoperatively and on day 3 after surgery. All SSIs and major complications were recorded during the postoperative stay or if patients were readmitted. Patients were scheduled for follow-up after 4 weeks. The nurses in the outpatient clinics were skilled in diagnosing SSI based on clinical findings such as purulent drainage, pain, swelling, redness, heat, and fever. When patients were not able to come to the outpatient clinics, they, or nursing home staff, were contacted by phone. In case of infection, the approach was mainly early reoperation with soft tissue debridement and retention of the implant. Several tissue samples were then obtained from the joint for culture. A minimum of 2 biopsies had to be positive with the same bacteria to regard the joint as infected. A medical records review of all patients was performed 6 months after the last patient was enrolled to detect any late infections or other surgical complications or deaths.
Statistical Methods
In a retrospective review in one of the hospitals in 2008 and 2009, a deep SSI rate of 9% was found in consecutive patients undergoing hemiarthroplasty because of a femoral neck fracture [6] . Simultaneously, infection rates of approximately 9% were found in 2 of the other hospitals ( personal communication from, H. W. and W. F.). The Norwegian Arthroplasty Register reported a 1-year incidence of SSI of 7.3% after hemiarthroplasty [5] . We therefore assumed an incidence of SSI (deep and superficial) of 9%. In the sample size calculations, we assumed a reduction of infection rate from 9% to 4%, based on the study from Friberg and colleagues [15] . We intended to recruit 381 patients in each group to achieve a power of 80% at a 2-sided type I error rate of 0.05. All analyses were based on a modified intention-totreat reporting. The 15 patients who were randomized to gentamicin sponges, but did not receive sponges, were not included in the analysis. The χ 2 test or Fisher exact test was used for comparing proportions, and independent samples t test was used to compare means in the crude analyses. Logistic regression analysis was used for the adjusted analyses of infection risk. A P value of <.05 was considered significant. We used SPSS for Windows, version 18.0 software (SPSS Inc, Chicago, Illinois). An interim analysis was planned and performed midway through the trial.
RESULTS
Overall, 739 eligible patients were included during the study period from February 2011 to July 2013. Figure 1 shows the trial profile. Six hundred eighty-four patients were included in the final analysis (329 in the gentamicin-collagen group and 355 in the control group). Of 631 patients, 493 (78%) were seen in the outpatient clinics for follow-up (243 in the gentamicincollagen group and 250 in the control group). One hundred thirty-eight patients were followed up by telephone (66 in the gentamicin-collagen group and 72 in the control group). Of these, all but 10 were staying at a nursing home or a rehabilitation clinic at the time of follow-up.
Demographics and Surgical Results
Baseline characteristics were similar between the 2 groups, except for sex (Table 1 ). In the gentamicin-collagen group, 226 of Figure 1 . Trial profile. A total of 1284 patients underwent hemiarthroplasty during the study period. Screening numbers are from 2 of 5 centers, including randomization numbers from the other 3 centers that did not provide a screening log. The term "inclusion error" includes instances when elevated serum creatinine levels were initially overlooked, where the operative procedure was changed in the operating room, and where there were missing inclusion papers.
329 (69%) were women, vs 281 of 355 (79%) in the control group. Surgical complications were evenly distributed between the 2 groups ( Table 2) . One patient died perioperatively following insertion of a cemented arthroplasty.
Primary Outcome
There was a small difference, but not statistically significant, in the frequency of SSIs in patients in the gentamicin-collagen group ( 
Secondary Outcomes
Subgroup analyses showed no statistically significant differences between the study groups ( Data on serum creatinine levels were available both preoperatively and on day 3 postoperatively in 555 patients. The increase in serum creatinine was higher in the gentamicincollagen group than in the control group (Table 3) .
Microbiology
The deep SSIs were culture positive in 25 of 30 patients. The majority of bacteria detected were S. aureus (12 of 30) and CoNS (6 of 30). Only 2 SSIs were due to gram-negative bacteria. No methicillin-resistant S. aureus was found. There were no differences in the microbial spectrum between the 2 groups (Table 3) .
Sensitivity Analyses
Due to a higher exclusion rate than expected, we did not manage to include the intended number of patients. A post hoc sensitivity analysis showed that the infection rate would have had to be 40% (10/26) in the remaining patients to be included in the control group to achieve a statistically significant difference between the groups. The observed SSI rate was lower (5.4%) than the 9% assumed in the sample size calculations, and the study therefore may be underpowered. If the study population was doubled and the infection rate of 5.4% in the control group remained unchanged, there would have to be only 4 SSIs (1%) in the gentamicin-collagen group to achieve a statistically significant difference.
DISCUSSION
To our knowledge, this is the first RCT on prophylactic use of gentamicin-containing collagen sponges in joint replacement surgery. Adding gentamicin-collagen sponges did not statistically significantly reduce the SSI rate in patients undergoing hemiarthroplasty following femoral neck fracture in this study. Several RCTs have evaluated the effectiveness of gentamicin-collagen sponges used as prophylaxis, especially in cardiac surgery, and the results are somewhat conflicting [15-18, 22, 23] . These diverse results may reflect that SSI is related to several risk factors, both patient-and surgery-dependent, and that different surgical modalities and organ systems have different infection profiles. Infection in the sternum closed with wires, as in cardiac surgery, is quite similar to an orthopedic infection with implants. However, our results contradict the findings of Friberg et al and Schimmer et al, who reported a relative reduction of 53% and 66%, respectively, of SSIs following median sternotomy [15, 18] . The microbiological findings in these trials are relatively comparable to the findings in our study, with the majority of infections caused by staphylococci and very few by gramnegative bacteria.
In contrast, Bennett-Guerrero et al reported no effect of gentamicin sponges in patients undergoing median sternotomy in a multicenter RCT [16] . The microbiological findings were different from our study with a relatively large proportion of gram-negative bacteria and few CoNS. BennettGuerrero and colleagues simultaneously published an RCT in colorectal surgery. This study also did not show an effect of the sponges; in fact, the incidence of SSI was higher in the treatment group [17] . The microbiological flora in this study was obviously different from both the cardiac surgery studies and our study. There has been some debate on the surgical technique for implantation of the sponges. In the 2 trials by Bennett-Guerrero et al, the sponges were presoaked in saline to facilitate implantation [16, 17, 24] . This may have affected the results, as wetting the sponges may reduce the gentamicin content [25] . Serum gentamicin concentrations were, however, similar in both studies by Bennett-Guerrero et al [16, 17] and in those reported by Friberg et al [13] , suggesting that even the presoaked sponges delivered a high concentration of gentamicin.
The literature on prophylactic use of gentamicin-collagen sponges in orthopedic surgery is scarce, and varies in methods and procedures [26] . To date, there are 5 studies in orthopedic surgery, of which 3 studies are on amputations in patients with diabetes in whom no implants are used. Rohde and colleagues found a significant reduction of SSI following lumbar discectomy [27] . The surgery in question was minimally invasive surgery in which no implants were used. The SSI diagnoses were not confirmed by cultures, and hence the infecting agents are unknown. The historical control group did not receive antibiotic prophylaxis at all, whereas in the present study, gentamicin sponges were given as an addition to systemic antimicrobial prophylaxis. In a case series report, Chaudhary and colleagues reported satisfactory results in patients with open fractures treated with plate osteosynthesis and local gentamicin-collagen sponges [28] . The total SSI rate was 5 of 31 (16%).
In contrast to the previous RCTs, S. aureus was the predominant pathogen in our study. In periprosthetic infections in the hip, the ratio between S. aureus and CoNS has been reported to be approximately 40% vs 20% [29] . This is similar to the findings in our study. The increased virulence of S. aureus and its affinity for surgial implants, may explain this, as the affinity for surgical implants. The patients in our study were elderly with multiple comorbidities known to be associated with periprosthetic infections with S. aureus [30, 31] . The location of the implant may also matter. CoNS are more frequently isolated in periprosthetic shoulder infections, as well as in cardiothoracic and spinal surgery.
We found that cognitive failure was a predictor of SSI. Cognitive failure may be associated with many factors also known to increase the risk of SSI such as malnutrition, postoperative delirium, and poor compliance. They often also have reduced functional status, which has been found to be an isolated predictor of SSI due to S. aureus [32] . These patients are more in contact with healthcare settings and institutions, and may thereby more often be colonized with staphylococci. They also may be exposed to antimicrobials, and their decreased mobility may lead to pressure sores.
There was a tendency toward the SSIs occurring later (median 6 days after initial surgery; P = .09) in the gentamicincollagen group than in the control group. The gentamicin sponge may lead to a delayed presentation of SSI by inhibiting bacteria growth for the first days when gentamicin release is high [13, 17] .
The mean increase in serum creatinine level was significantly higher in the gentamicin-collagen group compared with the control group. The increase was not clinically relevant, but it may reflect that the gentamicin-containing implants have a systemic effect.
There are limitations to the study. The multicenter design of the study implies that several surgeons and hospitals were involved. We did not change any procedures other than adding gentamicin-collagen sponges, but the causes of SSI are multifactorial and other factors may have influenced the results. Furthermore, the study population of elderly patients with an acute hip fracture is a heterogeneous population with several risk factors for infection. However, our multivariate analysis did not reveal significant risks for SSI, except for cognitive impairment. Moreover, we could not identify a specific factor causing the lack of efficacy of the sponges, nor was the study designed to assess the use of gentamicin sponges in SSI. Finally, the numbers included turned out to be fewer than calculated in the power analysis. There was no change in the primary end-point results between the interim analysis and the final analysis, and there were no differences in the subgroup analyses. A post hoc sensitivity anaylsis also showed that the conclusions unlikely would have changed if the estimated numbers of patients were included. The infection rate in the control group turned out to be lower than estimated in the power analysis. It is difficult to predict the frequency of SSI due to variation of infection rate over time and across institutions. The higher infection rates that lead to the calculation of sample size in the current study may be due to short registration periods, capturing a cluster of SSIs. Furthermore, the increased awareness by performing a study on SSI may lead to a decrease. A sensitivity analysis showed, however, that the results likely would have remained unchanged even when doubling the study population. We chose to study elderly patients undergoing arthroplasty after femoral neck fracture because they have an increased risk of SSI compared with patients undergoing elective total hip arthroplasty. As we were unable to find that the gentamicin sponges were effective in this population, it is unlikely that a relevant risk reduction would be demonstrated in a trial on elective hip arthroplasty.
In conclusion, locally administered gentamicin-collagen sponges did not reduce the incidence of SSI in this randomized multicenter trial.
Notes
